We firstly demonstrated that patients with ascites ≥500 ml (27.83 months vs. 13.7 months, p=0.12, HR 0.72), age ≥58 years (22.93 months vs. 13.53 months, p=0.354, HR 0.62), diameter of tumor<10cm (27.83 months vs. 12.80 months, p=0.095, HR 0.36), Ki-67 ≥70% (22.93 months vs. 13.53 months, p=0.093, HR 0.39) had a trend of better prognosis. This evidence concerns the gene MKI67 and neoplasm.